|
GORASP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.453800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.508300E-02 |
| Normal-vs-Stage2 |
7.988000E-01 |
| Normal-vs-Stage3 |
9.777500E-03 |
| Normal-vs-Stage4 |
8.804400E-02 |
| Stage1-vs-Stage2 |
4.491200E-01 |
| Stage1-vs-Stage3 |
3.344900E-03 |
| Stage1-vs-Stage4 |
4.654400E-02 |
| Stage2-vs-Stage3 |
1.039700E-02 |
| Stage2-vs-Stage4 |
8.280100E-02 |
| Stage3-vs-Stage4 |
7.189600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.210800E-01 |
| Normal-vs-AfricanAmerican |
8.017000E-01 |
| Normal-vs-Asian |
3.389000E-01 |
| Caucasian-vs-AfricanAmerican |
7.665200E-01 |
| Caucasian-vs-Asian |
1.848040E-01 |
| AfricanAmerican-vs-Asian |
2.143400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.842440E-01 |
| Normal-vs-Female |
5.776200E-03 |
| Male-vs-Female |
6.623600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.882000E-01 |
| Normal-vs-Extreme_Weight |
1.315980E-02 |
| Normal-vs-Obese |
1.752630E-01 |
| Normal-vs-Extreme_Obese |
4.349200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.378200E-02 |
| Normal_Weight-vs-Obese |
4.205400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.432800E-01 |
| Extreme_Weight-vs-Obese |
1.452090E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.992600E-01 |
| Obese-vs-Extreme_Obese |
1.364400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.700410E-02 |
| Normal-vs-Age(41-60Yrs) |
1.014550E-01 |
| Normal-vs-Age(61-80Yrs) |
1.207590E-02 |
| Normal-vs-Age(81-100Yrs) |
2.509400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.218000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.658500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.882600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.581200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.271800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.668400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.018200E-02 |
| Normal-VS-Type2 PRCC |
7.952200E-01 |
| Normal-VS-KIRP CIMP |
1.979520E-03 |
| Normal-VS-Unclassified PRCC |
2.209000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.035900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.384320E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.856200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.220600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.415000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.536100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.351400E-01 |
| Normal-vs-N1 |
1.741950E-03 |
| Normal-vs-N2 |
1.508180E-01 |
| N0-vs-N1 |
1.524360E-03 |
| N0-vs-N2 |
2.270300E-02 |
| N1-vs-N2 |
6.565400E-01 |
|
|
